{
  "report_rows": [
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$3.42B vs. cons $3.38B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$1.43B vs. cons $1.405B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.50 vs. cons $1.47",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted revenue",
      "prediction": "UNCHANGED",
      "answer": "guide ~$13.81B vs. cons $13.82B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EBITDA",
      "prediction": "UNCHANGED",
      "answer": "guide ~$5.83B vs. cons $5.84B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$6.27 vs. cons $6.28 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 free cash flow",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.10B vs. cons $2.10B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Issuing cost synergies",
      "prediction": "UNCHANGED",
      "answer": "guide ~$35M vs. prior target midpoint $35M (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "A modest Q2 beat can initially de-risk execution, but unchanged FY2026 guidance would imply ~$0.03 less second-half EPS versus pre-report consensus after absorbing the predicted Q2 beat, limiting upward revisions and causing most of the day-1 gain to fade.",
  "day5_confidence": "MEDIUM"
}